{"id":65836,"date":"2024-05-08T13:12:32","date_gmt":"2024-05-08T17:12:32","guid":{"rendered":"https:\/\/www.crchudequebec.ulaval.ca\/platforms-and-services\/medecine-regeneratrice\/reprogrammation-cellulaire-cellules-ips\/"},"modified":"2024-06-27T15:53:14","modified_gmt":"2024-06-27T19:53:14","slug":"reprogrammation-cellulaire-cellules-ips","status":"publish","type":"page","link":"https:\/\/www.crchudequebec.ulaval.ca\/en\/platforms-and-services\/medecine-regeneratrice\/reprogrammation-cellulaire-cellules-ips\/","title":{"rendered":"Cellular Reprogramming (IPS cells)"},"content":{"rendered":"\n
<\/div>\n\n\n
\n
\n
\n
\n
\n
\n \n \n
\n

Director<\/h3>\n \n
\n Fran\u00e7ois Gros-Louis, Ph. D. \n <\/div>\n \n \n \n <\/div>\n
\n

Manager<\/h3>\n \n
\n Laurie Martineau, M. Sc.\n <\/div>\n \n \n \n <\/div>\n
\n

Stem cells production at the CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center<\/h3>\n \n
\n CMDGT\/LOEX, R Wing
\r\n1401 18th street
\r\nQuebec, Qc
\r\nG1J 1Z4
\r\nCanada \n <\/div>\n \n
\n \n 1-418-525-4444, extension 61707 <\/a>\n <\/div>\n \n \n <\/div>\n \n \n \n \n <\/div>\n
\n \n \n
\n
\n

The induced pluripotent stem cell (iPSC) production platform at the CRCHU de Qu\u00e9bec specializes in reprogramming somatic cells into iPSCs from various sources such as skin, blood, urine, etc. It also offers training opportunities for the culture and utilization of these cells. With over 200 reprogramming cases completed, the iPSC platform is capable of delivering high-quality services at competitive prices to all academic researchers at the CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center and throughout the province of Quebec. Its services are also available to researchers from other provinces and countries.<\/span>\u00a0<\/span><\/p>\n

In summary:<\/span>\u00a0<\/span><\/p>\n